516 related articles for article (PubMed ID: 23941362)
1. Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C--a randomized trial.
Rusu E; Jinga M; Enache G; Rusu F; Dragomir AD; Ancuta I; Draguţ R; Parpala C; Nan R; Sima I; Ateia S; Stoica V; Cheţa DM; Radulian G
Nutr J; 2013 Aug; 12():119. PubMed ID: 23941362
[TBL] [Abstract][Full Text] [Related]
2. Gender Differences in Liver Steatosis and Fibrosis in Overweight and Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease before and after 8 Weeks of Very Low-Calorie Ketogenic Diet.
Rinaldi R; De Nucci S; Donghia R; Donvito R; Cerabino N; Di Chito M; Penza A; Mongelli FP; Shahini E; Zappimbulso M; Pesole PL; Coletta S; Triggiani V; Cozzolongo R; Giannelli G; De Pergola G
Nutrients; 2024 May; 16(10):. PubMed ID: 38794646
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V
Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983
[TBL] [Abstract][Full Text] [Related]
4. The effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
Alami F; Alizadeh M; Shateri K
Scand J Gastroenterol; 2022 Oct; 57(10):1238-1249. PubMed ID: 35710164
[TBL] [Abstract][Full Text] [Related]
5. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
[TBL] [Abstract][Full Text] [Related]
6. Liver enzymes but not free fatty acid levels predict markers of insulin sensitivity in overweight and obese, nondiabetic adults.
Gray B; Muhlhausler BS; Davies PS; Vitetta L
Nutr Res; 2013 Oct; 33(10):781-8. PubMed ID: 24074735
[TBL] [Abstract][Full Text] [Related]
7. Dietary approaches to stop hypertension (DASH) diet improves hepatic fibrosis, steatosis and liver enzymes in patients with non-alcoholic fatty liver disease: a randomized controlled trial.
Sangouni AA; Nadjarzadeh A; Rohani FS; Sharuni F; Zare Z; Rahimpour S; Hojjat H; Hosseinzadeh M
Eur J Nutr; 2024 Feb; 63(1):95-105. PubMed ID: 37855891
[TBL] [Abstract][Full Text] [Related]
8. Associations of physical activity and fitness with hepatic steatosis, liver enzymes, and insulin resistance in children with overweight/obesity.
Medrano M; Arenaza L; Migueles JH; Rodríguez-Vigil B; Ruiz JR; Labayen I
Pediatr Diabetes; 2020 Jun; 21(4):565-574. PubMed ID: 32237015
[TBL] [Abstract][Full Text] [Related]
9. Effect of soy protein supplementation in patients with chronic hepatitis C: a randomized clinical trial.
Oliveira LP; de Jesus RP; Boulhosa RS; Mendes CM; Gnoatto MC; Lemaire DC; Toralles MB; Cavalcante LN; Lyra AC; Lyra LG
World J Gastroenterol; 2012 May; 18(18):2203-11. PubMed ID: 22611313
[TBL] [Abstract][Full Text] [Related]
10. Predictors of hepatic steatosis in HBeAg-negative chronic hepatitis B patients and their diagnostic values in hepatic fibrosis.
Zheng RD; Xu CR; Jiang L; Dou AX; Zhou K; Lu LG
Int J Med Sci; 2010 Aug; 7(5):272-7. PubMed ID: 20714438
[TBL] [Abstract][Full Text] [Related]
11. Clinical and virological characteristics of chronic hepatitis B patients with hepatic steatosis.
Zheng RD; Chen JN; Zhuang QY; Lu YH; Chen J; Chen BF
Int J Med Sci; 2013; 10(5):641-6. PubMed ID: 23569427
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Extra Virgin Olive Oil on Alanine Aminotransferase, Aspartate Aminotransferase, and Ultrasonographic Indices of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients Undergoing Low Calorie Diet.
Shidfar F; Bahrololumi SS; Doaei S; Mohammadzadeh A; Gholamalizadeh M; Mohammadimanesh A
Can J Gastroenterol Hepatol; 2018; 2018():1053710. PubMed ID: 29850450
[TBL] [Abstract][Full Text] [Related]
13. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
[TBL] [Abstract][Full Text] [Related]
14. Fruit Fiber Consumption Specifically Improves Liver Health Status in Obese Subjects under Energy Restriction.
Cantero I; Abete I; Monreal JI; Martinez JA; Zulet MA
Nutrients; 2017 Jun; 9(7):. PubMed ID: 28657604
[TBL] [Abstract][Full Text] [Related]
15. Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse.
Sterling RK; Smith PG; Brunt EM
J Clin Gastroenterol; 2013 Feb; 47(2):182-7. PubMed ID: 23059409
[TBL] [Abstract][Full Text] [Related]
16. Gut Permeability Might be Improved by Dietary Fiber in Individuals with Nonalcoholic Fatty Liver Disease (NAFLD) Undergoing Weight Reduction.
Krawczyk M; Maciejewska D; Ryterska K; Czerwińka-Rogowska M; Jamioł-Milc D; Skonieczna-Żydecka K; Milkiewicz P; Raszeja-Wyszomirska J; Stachowska E
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453660
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effect of rapeseed oil or amaranth seed oil supplementation on weight loss, body composition, and changes in the metabolic profile of obese patients following 3-week body mass reduction program: a randomized clinical trial.
Moszak M; Zawada A; Juchacz A; Grzymisławski M; Bogdański P
Lipids Health Dis; 2020 Jun; 19(1):143. PubMed ID: 32563253
[TBL] [Abstract][Full Text] [Related]
18. Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease.
Ristic-Medic D; Kovacic M; Takic M; Arsic A; Petrovic S; Paunovic M; Jovicic M; Vucic V
Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374554
[TBL] [Abstract][Full Text] [Related]
19. Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients.
Ricci G; Bersani G; Rossi A; Pigò F; De Fabritiis G; Alvisi V
Obes Surg; 2008 Nov; 18(11):1438-42. PubMed ID: 18369681
[TBL] [Abstract][Full Text] [Related]
20. A meal replacement regimen improves blood glucose levels in prediabetic healthy individuals with impaired fasting glucose.
König D; Kookhan S; Schaffner D; Deibert P; Berg A
Nutrition; 2014; 30(11-12):1306-9. PubMed ID: 25194963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]